Posted October 3, 2011
Tuesday, October 4 5:30 pm in the Biotech Auditorium, William Edelman '78 will speak to the undergraduates.
Bill Edelman, is a medical device industry executive with over 33 years of experience and currently serves as Chairman of the Board at Leviticus Cardio, Ltd. He has served as Co-Chairman for ETView, Ltd., (TASE: ETVW) (airway management), Chairman of the Board for PolyTouch, Ltd. (general surgical instrumentation), Medivalve, Ltd., (percutaneous aortic valve placement) and Cardioflow, Ltd., (embolic protection). Mr. Edelman also serves as an Advisor on the Heathcare Board, for Northeast Securities, Inc., a member of the Screening Committee, Medical Devices for Mass Medical Angels, a member of the Advisory Counsel for the Department of Biomedical Engineering at Rensselaer as well as an Advisor to Highland Instruments, Inc., and MindChild Medical, Inc. Mr. Edelman recently served as COB for Stimatix GI, Ltd., (ostomy products). Mr. Edelman was most recently President & Chief Executive Officer, TYRX, Inc., a commercial stage venture backed medical device company focused in drug/device implant products for general surgery, electrophysiology and cosmetic surgery. Prior to TYRX, Mr. Edelman held executive level positions at MicroSense International, LLC (bio-sensing), FibraSonics, Inc. (ultrasonic surgical products), NeuroMod, Inc. (neuro-stimulation technologies), St. Jude Medical, Inc. (NYSE: STJ), Pfizer, Inc. (NYSE: PFE), and Baxter International, Inc. (NYSE: BAX). Mr. Edelman graduated with a degree in Biomedical Engineering from Rensselaer Polytechnic Institute (78). He has been issued 15 U.S. patents and is an applicant on 3 additional pending patent applications.